Rationale and design of a randomized clinical trial of beta blocker therapy (atenolol) vs. angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

Document Type

Journal Article

Publication Date

2007

Journal

Am Heart J

Volume

154

Inclusive Pages

624-631

Keywords

Pediatrics

This document is currently not available here.

Share

COinS